DrugPatentWatch Database Preview
Collegium Pharm Inc Company Profile
What is the competitive landscape for COLLEGIUM PHARM INC, and what generic alternatives to COLLEGIUM PHARM INC drugs are available?
COLLEGIUM PHARM INC has one approved drug.
There are fourteen US patents protecting COLLEGIUM PHARM INC drugs.
There are seventeen patent family members on COLLEGIUM PHARM INC drugs in eleven countries and one supplementary protection certificate in one country.
Summary for Collegium Pharm Inc
| International Patents: | 17 |
| US Patents: | 14 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Collegium Pharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-004 | Apr 26, 2016 | RX | Yes | No | 9,968,598 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-001 | Apr 26, 2016 | RX | Yes | No | 9,968,598 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-002 | Apr 26, 2016 | RX | Yes | No | 9,044,398 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-004 | Apr 26, 2016 | RX | Yes | No | 9,248,195 | ➤ Sign Up | ➤ Sign Up | ||||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-004 | Apr 26, 2016 | RX | Yes | No | 9,044,398 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-003 | Apr 26, 2016 | RX | Yes | No | 9,737,530 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Collegium Pharm Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Portugal | 1765292 | ➤ Sign Up |
| European Patent Office | 1594467 | ➤ Sign Up |
| Canada | 2491572 | ➤ Sign Up |
| European Patent Office | 3326617 | ➤ Sign Up |
| Poland | 1765292 | ➤ Sign Up |
| Slovenia | 1765292 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Collegium Pharm Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 292 | Luxembourg | ➤ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
